Literature DB >> 20060626

Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics".

M Muscaritoli1, S D Anker, J Argilés, Z Aversa, J M Bauer, G Biolo, Y Boirie, I Bosaeus, T Cederholm, P Costelli, K C Fearon, A Laviano, M Maggio, F Rossi Fanelli, S M Schneider, A Schols, C C Sieber.   

Abstract

Chronic diseases as well as aging are frequently associated with deterioration of nutritional status, loss muscle mass and function (i.e. sarcopenia), impaired quality of life and increased risk for morbidity and mortality. Although simple and effective tools for the accurate screening, diagnosis and treatment of malnutrition have been developed during the recent years, its prevalence still remains disappointingly high and its impact on morbidity, mortality and quality of life clinically significant. Based on these premises, the Special Interest Group (SIG) on cachexia-anorexia in chronic wasting diseases was created within ESPEN with the aim of developing and spreading the knowledge on the basic and clinical aspects of cachexia and anorexia as well as of increasing the awareness of cachexia among health professionals and care givers. The definition, the assessment and the staging of cachexia, were identified as a priority by the SIG. This consensus paper reports the definition of cachexia, pre-cachexia and sarcopenia as well as the criteria for the differentiation between cachexia and other conditions associated with sarcopenia, which have been developed in cooperation with the ESPEN SIG on nutrition in geriatrics. Copyright 2009 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20060626     DOI: 10.1016/j.clnu.2009.12.004

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  419 in total

1.  JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia.

Authors:  Andrea Bonetto; Tufan Aydogdu; Xiaoling Jin; Zongxiu Zhang; Rui Zhan; Leopold Puzis; Leonidas G Koniaris; Teresa A Zimmers
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-06-05       Impact factor: 4.310

Review 2.  How to assess functional status: a new muscle quality index.

Authors:  S Barbat-Artigas; Y Rolland; M Zamboni; M Aubertin-Leheudre
Journal:  J Nutr Health Aging       Date:  2012-01       Impact factor: 4.075

Review 3.  Muscle atrophy in aging and chronic diseases: is it sarcopenia or cachexia?

Authors:  Maurizio Muscaritoli; Simone Lucia; Alessio Molfino; Tommy Cederholm; Filippo Rossi Fanelli
Journal:  Intern Emerg Med       Date:  2012-07-08       Impact factor: 3.397

4.  Evaluation of the Usefulness of Consensus Definitions of Sarcopenia in Older Men: Results from the Observational Osteoporotic Fractures in Men Cohort Study.

Authors:  Peggy M Cawthon; Terri L Blackwell; Jane Cauley; Deborah M Kado; Elizabeth Barrett-Connor; Christine G Lee; Andrew R Hoffman; Michael Nevitt; Marcia L Stefanick; Nancy E Lane; Kristine E Ensrud; Steven R Cummings; Eric S Orwoll
Journal:  J Am Geriatr Soc       Date:  2015-10-27       Impact factor: 5.562

Review 5.  The emerging role of skeletal muscle oxidative metabolism as a biological target and cellular regulator of cancer-induced muscle wasting.

Authors:  James A Carson; Justin P Hardee; Brandon N VanderVeen
Journal:  Semin Cell Dev Biol       Date:  2015-12-01       Impact factor: 7.727

6.  The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trial.

Authors:  Jenny G Turcott; María Del Rocío Guillen Núñez; Diana Flores-Estrada; Luis F Oñate-Ocaña; Zyanya Lucia Zatarain-Barrón; Feliciano Barrón; Oscar Arrieta
Journal:  Support Care Cancer       Date:  2018-03-17       Impact factor: 3.603

7.  Understanding tumor anabolism and patient catabolism in cancer-associated cachexia.

Authors:  Alejandro Schcolnik-Cabrera; Alma Chávez-Blanco; Guadalupe Domínguez-Gómez; Alfonso Dueñas-González
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

Review 8.  Muscle wasting and cachexia in heart failure: mechanisms and therapies.

Authors:  Stephan von Haehling; Nicole Ebner; Marcelo R Dos Santos; Jochen Springer; Stefan D Anker
Journal:  Nat Rev Cardiol       Date:  2017-04-24       Impact factor: 32.419

Review 9.  Diagnostic imaging of osteoporosis and sarcopenia: a narrative review.

Authors:  Carmelo Messina; Gabriele Maffi; Jacopo Antonino Vitale; Fabio Massimo Ulivieri; Giuseppe Guglielmi; Luca Maria Sconfienza
Journal:  Quant Imaging Med Surg       Date:  2018-02

10.  Reproducibility of jumping mechanography and traditional measures of physical and muscle function in older adults.

Authors:  B Buehring; D Krueger; E Fidler; R Gangnon; B Heiderscheit; N Binkley
Journal:  Osteoporos Int       Date:  2014-12-09       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.